Jing Wang

机构：University of Pittsburgh, First People's Hospital of Yuhang District, University of Pittsburgh Medical Center, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine · ORCID：0000-0003-4343-2527

发表论文 239 篇 · 总被引 6655 次 · h-index 46

代表论文

Probiotics for ulcerative colitis: mechanisms, therapeutic advances, and emerging strategies (2026 · Frontiers in Microbiology · 被引 6)
Tumor-derived PTX3 drives an immunosuppressive myeloid landscape and inhibits CD8 T cell-mediated anti-tumor immunity via PI3K-dependent signaling (2026 · Oncogene)
Supplementary Table S8 from Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors (2026)
Supplementary Table S14 from Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors (2026)
Supplementary Table S2 from Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors (2026)
Supplementary Table S6 from Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors (2026)